Home »
Researchers in England say they have the first evidence that a drug can improve COVID-19 survival: A cheap, widely available steroid called dexamethasone reduced deaths by up to one third in severely ill hospitalized patients. Results were announced Tuesday and researchers said they would publish them soon. The study is a large, strict test that randomly assigned 2,104 patients to […]
Read more
In an international trial led by researchers at The University of Texas MD Anderson Cancer Center, treatment with MK-6482, the small molecule inhibitor of hypoxia-inducible factor (HIF)-2a was well tolerated and resulted in clinical responses for patients with von Hippel-Lindau disease (VHL)-associated renal cell carcinoma (RCC). The results of the Phase II trial were shared today in an oral presentation […]
Read more
Results from a study of adults with kidney failure suggest that taking both short-acting benzodiazepines and opioids may put patients at an especially high risk of dying prematurely. The findings appear in an upcoming issue of CJASN. Increasing use of opioids in recent years has led to rising numbers of deaths and hospitalizations due to overdoses. In light of this […]
Read more
BREAKING NEWS: FDA may approve emergency use authorization of Ebola drug remdesivir TODAY after Dr Fauci called early results of one study ‘very optimistic’ The FDA may announce its decision allowing emergency use authorization of an antiviral remdesivir for coronavirus patients as early as Wednesday It comes as Gilead Sciences treated 397 severely ill patients and found more than half of […]
Read more
State and local governments across the United States have obtained more than 30 million doses of a malaria drug touted by President Trump to treat patients with the new coronavirus, despite warnings from doctors that more research is needed. At least 22 states and Washington, D.C. secured shipments of the drug, hydroxychloroquine, according to information compiled from state and federal […]
Read more
Francesco Stellacci, a professor in EPFL’s School of Engineering, discusses his research in the field of nanomedicine and how it could help us get past the coronavirus crisis. As the COVID-19 outbreak rages on, researchers are in a race against the clock to find some way to combat the coronavirus. Francesco Stellacci, the professor who heads the Supramolecular Nano-Materials and […]
Read more
Chronic migraine sufferers are given fresh hope of getting rid of their crippling headaches with first new drug in 20 years New drug self-injected at home will benefit 10,000 people suffering migraines Fremanezumab was developed by UK scientists over three decades In trials the drug has reduced the frequency, severity and duration of migraines Lead researcher called the introduction of […]
Read more
Broken bones could regrow after injury using a drug cocktail that triggers the release of ‘red alert’ repair cells Two drugs already available have been combined and tested on rats They work together to trigger the release of stem cells from the bone marrow Stem cells built new bone in rats’ spines and sped up the healing process Now the […]
Read more
THURSDAY, Feb. 13, 2020 — Ketamine use among electronic dance music party-goers is much higher than previously thought. And unintentional use appears to play a role, a new study finds. Ketamine is known as Special K on the party scene. The operating room anesthetic was approved by the U.S. Food and Drug Administration in 2019 as a treatment for depression. […]
Read more
In a UCLA-led phase I clinical trial, a new plant-based drug called APG-157 showed signs of helping patients fight oral and oropharyngeal cancers. These cancers are located in the head and the neck. APG-157 is made up of multiple compounds produced by plants, including curcumin. UCLA Jonsson Comprehensive Cancer Center researchers found that treatment with this botanical drug resulted in […]
Read more